Global Gene Therapy On Cardiovascular Disease Market Research Report 2026(Status and Outlook)
Gene therapy is an experimental technique that uses genes to treat or prevent disease. In the future, this technique may allow doctors to treat a disorder by inserting a gene into a patient's cells instead of using drugs or surgery. Although several conventional small-molecule treatments are available for common cardiovascular problems, gene therapy is a potential treatment option for acquired and inherited cardiovascular diseases that remain with unmet clinical needs.Market Driver: The increasing prevalence of cardiovascular diseases (CVDs) worldwide is a major driver for the gene therapy market in this area. As traditional treatments, such as surgery, medications, and lifestyle changes, sometimes fail to offer long-term solutions, gene therapy presents a promising alternative. By targeting the root causes of CVDs at the genetic level, gene therapy offers the potential for more effective and durable treatments. Advancements in gene editing technologies, such as CRISPR, have further accelerated the development of gene therapies for cardiovascular diseases, allowing for precise modification of genes that regulate heart function, blood vessel health, and inflammation. This technological progress, combined with the growing demand for personalized and innovative treatments, is driving the market forward.Market Challenge: Despite its potential, the gene therapy market for cardiovascular diseases faces several challenges, including high development costs and the complexity of clinical trials. Developing safe and effective gene therapies requires significant investment in research and long-term testing, which can delay the availability of these therapies to patients. Additionally, regulatory approval for gene therapies can be slow and uncertain, creating barriers to rapid commercialization. Moreover, there are concerns regarding the long-term safety and potential unintended genetic consequences of modifying human DNA, which may limit widespread adoption. The complexity of delivering gene therapies to the cardiovascular system, such as targeting specific cells or tissues without causing adverse effects, remains a significant technical challenge.Global key players of Gene Therapy On Cardiovascular Disease include Biogen, Novartis, Gilead Sciences, Sarepta Therapeutics, Alnylam Pharmaceuticals and Amgen, etc. Top three players occupy for a share about 76%.
The global Gene Therapy On Cardiovascular Disease market size was estimated at USD 322.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 91.00% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Gene Therapy On Cardiovascular Disease market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Gene Therapy On Cardiovascular Disease market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Gene Therapy On Cardiovascular Disease market.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Gene Therapy On Cardiovascular Disease Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Gene Therapy On Cardiovascular Disease, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
The global Gene Therapy On Cardiovascular Disease market size was estimated at USD 322.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 91.00% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Gene Therapy On Cardiovascular Disease market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Gene Therapy On Cardiovascular Disease market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Gene Therapy On Cardiovascular Disease market.
Global Gene Therapy On Cardiovascular Disease Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
- Renovacor
- Gene Biotherapeutics
- AskBio
- Human Stem Cells Institute
- Novartis
- Biogen
- Gilead Sciences
- SareptaTherapeutics
- Alnylam Pharmaceuticals
- Amgen
- Spark Therapeutics
- Akcea Therapeutics
- Sunway Biotech
- SIBIONO
- AnGes
- Orchard Therapeutics
Market Segmentation (by Type)
- Viral Gene Therapy
- Non-Viral Gene Therapy
Market Segmentation (by Application)
- Heart Disease
- Vascular Disease
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Gene Therapy On Cardiovascular Disease Market
Overview of the regional outlook of the Gene Therapy On Cardiovascular Disease Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Gene Therapy On Cardiovascular Disease Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Gene Therapy On Cardiovascular Disease, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Gene Therapy On Cardiovascular Disease
1.2 Key Market Segments
1.2.1 Gene Therapy On Cardiovascular Disease Segment by Type
1.2.2 Gene Therapy On Cardiovascular Disease Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 GENE THERAPY ON CARDIOVASCULAR DISEASE MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Gene Therapy On Cardiovascular Disease Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Gene Therapy On Cardiovascular Disease Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 GENE THERAPY ON CARDIOVASCULAR DISEASE MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Gene Therapy On Cardiovascular Disease Product Life Cycle
3.3 Global Gene Therapy On Cardiovascular Disease Sales by Manufacturers (2020-2025)
3.4 Global Gene Therapy On Cardiovascular Disease Revenue Market Share by Manufacturers (2020-2025)
3.5 Gene Therapy On Cardiovascular Disease Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Gene Therapy On Cardiovascular Disease Average Price by Manufacturers (2020-2025)
3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
3.8 Gene Therapy On Cardiovascular Disease Market Competitive Situation and Trends
3.8.1 Gene Therapy On Cardiovascular Disease Market Concentration Rate
3.8.2 Global 5 and 10 Largest Gene Therapy On Cardiovascular Disease Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 GENE THERAPY ON CARDIOVASCULAR DISEASE INDUSTRY CHAIN ANALYSIS
4.1 Gene Therapy On Cardiovascular Disease Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF GENE THERAPY ON CARDIOVASCULAR DISEASE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Gene Therapy On Cardiovascular Disease Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy – April 2025
5.6.3 Global Trade Frictions and Their Impacts to Gene Therapy On Cardiovascular Disease Market
5.7 ESG Ratings of Leading Companies
6 GENE THERAPY ON CARDIOVASCULAR DISEASE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Gene Therapy On Cardiovascular Disease Sales Market Share by Type (2020-2025)
6.3 Global Gene Therapy On Cardiovascular Disease Market Size by Type (2020-2025)
6.4 Global Gene Therapy On Cardiovascular Disease Price by Type (2020-2025)
7 GENE THERAPY ON CARDIOVASCULAR DISEASE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Gene Therapy On Cardiovascular Disease Market Sales by Application (2020-2025)
7.3 Global Gene Therapy On Cardiovascular Disease Market Size (M USD) by Application (2020-2025)
7.4 Global Gene Therapy On Cardiovascular Disease Sales Growth Rate by Application (2020-2025)
8 GENE THERAPY ON CARDIOVASCULAR DISEASE MARKET SALES BY REGION
8.1 Global Gene Therapy On Cardiovascular Disease Sales by Region
8.1.1 Global Gene Therapy On Cardiovascular Disease Sales by Region
8.1.2 Global Gene Therapy On Cardiovascular Disease Sales Market Share by Region
8.2 Global Gene Therapy On Cardiovascular Disease Market Size by Region
8.2.1 Global Gene Therapy On Cardiovascular Disease Market Size by Region
8.2.2 Global Gene Therapy On Cardiovascular Disease Market Size by Region
8.3 North America
8.3.1 North America Gene Therapy On Cardiovascular Disease Sales by Country
8.3.2 North America Gene Therapy On Cardiovascular Disease Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Gene Therapy On Cardiovascular Disease Sales by Country
8.4.2 Europe Gene Therapy On Cardiovascular Disease Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Gene Therapy On Cardiovascular Disease Sales by Region
8.5.2 Asia Pacific Gene Therapy On Cardiovascular Disease Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Gene Therapy On Cardiovascular Disease Sales by Country
8.6.2 South America Gene Therapy On Cardiovascular Disease Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Gene Therapy On Cardiovascular Disease Sales by Region
8.7.2 Middle East and Africa Gene Therapy On Cardiovascular Disease Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 GENE THERAPY ON CARDIOVASCULAR DISEASE MARKET PRODUCTION BY REGION
9.1 Global Production of Gene Therapy On Cardiovascular Disease by Region(2020-2025)
9.2 Global Gene Therapy On Cardiovascular Disease Revenue Market Share by Region (2020-2025)
9.3 Global Gene Therapy On Cardiovascular Disease Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Gene Therapy On Cardiovascular Disease Production
9.4.1 North America Gene Therapy On Cardiovascular Disease Production Growth Rate (2020-2025)
9.4.2 North America Gene Therapy On Cardiovascular Disease Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Gene Therapy On Cardiovascular Disease Production
9.5.1 Europe Gene Therapy On Cardiovascular Disease Production Growth Rate (2020-2025)
9.5.2 Europe Gene Therapy On Cardiovascular Disease Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Gene Therapy On Cardiovascular Disease Production (2020-2025)
9.6.1 Japan Gene Therapy On Cardiovascular Disease Production Growth Rate (2020-2025)
9.6.2 Japan Gene Therapy On Cardiovascular Disease Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Gene Therapy On Cardiovascular Disease Production (2020-2025)
9.7.1 China Gene Therapy On Cardiovascular Disease Production Growth Rate (2020-2025)
9.7.2 China Gene Therapy On Cardiovascular Disease Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Renovacor
10.1.1 Renovacor Basic Information
10.1.2 Renovacor Gene Therapy On Cardiovascular Disease Product Overview
10.1.3 Renovacor Gene Therapy On Cardiovascular Disease Product Market Performance
10.1.4 Renovacor Business Overview
10.1.5 Renovacor SWOT Analysis
10.1.6 Renovacor Recent Developments
10.2 Gene Biotherapeutics
10.2.1 Gene Biotherapeutics Basic Information
10.2.2 Gene Biotherapeutics Gene Therapy On Cardiovascular Disease Product Overview
10.2.3 Gene Biotherapeutics Gene Therapy On Cardiovascular Disease Product Market Performance
10.2.4 Gene Biotherapeutics Business Overview
10.2.5 Gene Biotherapeutics SWOT Analysis
10.2.6 Gene Biotherapeutics Recent Developments
10.3 AskBio
10.3.1 AskBio Basic Information
10.3.2 AskBio Gene Therapy On Cardiovascular Disease Product Overview
10.3.3 AskBio Gene Therapy On Cardiovascular Disease Product Market Performance
10.3.4 AskBio Business Overview
10.3.5 AskBio SWOT Analysis
10.3.6 AskBio Recent Developments
10.4 Human Stem Cells Institute
10.4.1 Human Stem Cells Institute Basic Information
10.4.2 Human Stem Cells Institute Gene Therapy On Cardiovascular Disease Product Overview
10.4.3 Human Stem Cells Institute Gene Therapy On Cardiovascular Disease Product Market Performance
10.4.4 Human Stem Cells Institute Business Overview
10.4.5 Human Stem Cells Institute Recent Developments
10.5 Novartis
10.5.1 Novartis Basic Information
10.5.2 Novartis Gene Therapy On Cardiovascular Disease Product Overview
10.5.3 Novartis Gene Therapy On Cardiovascular Disease Product Market Performance
10.5.4 Novartis Business Overview
10.5.5 Novartis Recent Developments
10.6 Biogen
10.6.1 Biogen Basic Information
10.6.2 Biogen Gene Therapy On Cardiovascular Disease Product Overview
10.6.3 Biogen Gene Therapy On Cardiovascular Disease Product Market Performance
10.6.4 Biogen Business Overview
10.6.5 Biogen Recent Developments
10.7 Gilead Sciences
10.7.1 Gilead Sciences Basic Information
10.7.2 Gilead Sciences Gene Therapy On Cardiovascular Disease Product Overview
10.7.3 Gilead Sciences Gene Therapy On Cardiovascular Disease Product Market Performance
10.7.4 Gilead Sciences Business Overview
10.7.5 Gilead Sciences Recent Developments
10.8 SareptaTherapeutics
10.8.1 SareptaTherapeutics Basic Information
10.8.2 SareptaTherapeutics Gene Therapy On Cardiovascular Disease Product Overview
10.8.3 SareptaTherapeutics Gene Therapy On Cardiovascular Disease Product Market Performance
10.8.4 SareptaTherapeutics Business Overview
10.8.5 SareptaTherapeutics Recent Developments
10.9 Alnylam Pharmaceuticals
10.9.1 Alnylam Pharmaceuticals Basic Information
10.9.2 Alnylam Pharmaceuticals Gene Therapy On Cardiovascular Disease Product Overview
10.9.3 Alnylam Pharmaceuticals Gene Therapy On Cardiovascular Disease Product Market Performance
10.9.4 Alnylam Pharmaceuticals Business Overview
10.9.5 Alnylam Pharmaceuticals Recent Developments
10.10 Amgen
10.10.1 Amgen Basic Information
10.10.2 Amgen Gene Therapy On Cardiovascular Disease Product Overview
10.10.3 Amgen Gene Therapy On Cardiovascular Disease Product Market Performance
10.10.4 Amgen Business Overview
10.10.5 Amgen Recent Developments
10.11 Spark Therapeutics
10.11.1 Spark Therapeutics Basic Information
10.11.2 Spark Therapeutics Gene Therapy On Cardiovascular Disease Product Overview
10.11.3 Spark Therapeutics Gene Therapy On Cardiovascular Disease Product Market Performance
10.11.4 Spark Therapeutics Business Overview
10.11.5 Spark Therapeutics Recent Developments
10.12 Akcea Therapeutics
10.12.1 Akcea Therapeutics Basic Information
10.12.2 Akcea Therapeutics Gene Therapy On Cardiovascular Disease Product Overview
10.12.3 Akcea Therapeutics Gene Therapy On Cardiovascular Disease Product Market Performance
10.12.4 Akcea Therapeutics Business Overview
10.12.5 Akcea Therapeutics Recent Developments
10.13 Sunway Biotech
10.13.1 Sunway Biotech Basic Information
10.13.2 Sunway Biotech Gene Therapy On Cardiovascular Disease Product Overview
10.13.3 Sunway Biotech Gene Therapy On Cardiovascular Disease Product Market Performance
10.13.4 Sunway Biotech Business Overview
10.13.5 Sunway Biotech Recent Developments
10.14 SIBIONO
10.14.1 SIBIONO Basic Information
10.14.2 SIBIONO Gene Therapy On Cardiovascular Disease Product Overview
10.14.3 SIBIONO Gene Therapy On Cardiovascular Disease Product Market Performance
10.14.4 SIBIONO Business Overview
10.14.5 SIBIONO Recent Developments
10.15 AnGes
10.15.1 AnGes Basic Information
10.15.2 AnGes Gene Therapy On Cardiovascular Disease Product Overview
10.15.3 AnGes Gene Therapy On Cardiovascular Disease Product Market Performance
10.15.4 AnGes Business Overview
10.15.5 AnGes Recent Developments
10.16 Orchard Therapeutics
10.16.1 Orchard Therapeutics Basic Information
10.16.2 Orchard Therapeutics Gene Therapy On Cardiovascular Disease Product Overview
10.16.3 Orchard Therapeutics Gene Therapy On Cardiovascular Disease Product Market Performance
10.16.4 Orchard Therapeutics Business Overview
10.16.5 Orchard Therapeutics Recent Developments
11 GENE THERAPY ON CARDIOVASCULAR DISEASE MARKET FORECAST BY REGION
11.1 Global Gene Therapy On Cardiovascular Disease Market Size Forecast
11.2 Global Gene Therapy On Cardiovascular Disease Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Gene Therapy On Cardiovascular Disease Market Size Forecast by Country
11.2.3 Asia Pacific Gene Therapy On Cardiovascular Disease Market Size Forecast by Region
11.2.4 South America Gene Therapy On Cardiovascular Disease Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Gene Therapy On Cardiovascular Disease by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Gene Therapy On Cardiovascular Disease Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Gene Therapy On Cardiovascular Disease by Type (2026-2035)
12.1.2 Global Gene Therapy On Cardiovascular Disease Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Gene Therapy On Cardiovascular Disease by Type (2026-2035)
12.2 Global Gene Therapy On Cardiovascular Disease Market Forecast by Application (2026-2035)
12.2.1 Global Gene Therapy On Cardiovascular Disease Sales (K Units) Forecast by Application
12.2.2 Global Gene Therapy On Cardiovascular Disease Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Gene Therapy On Cardiovascular Disease
1.2 Key Market Segments
1.2.1 Gene Therapy On Cardiovascular Disease Segment by Type
1.2.2 Gene Therapy On Cardiovascular Disease Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 GENE THERAPY ON CARDIOVASCULAR DISEASE MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Gene Therapy On Cardiovascular Disease Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Gene Therapy On Cardiovascular Disease Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 GENE THERAPY ON CARDIOVASCULAR DISEASE MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Gene Therapy On Cardiovascular Disease Product Life Cycle
3.3 Global Gene Therapy On Cardiovascular Disease Sales by Manufacturers (2020-2025)
3.4 Global Gene Therapy On Cardiovascular Disease Revenue Market Share by Manufacturers (2020-2025)
3.5 Gene Therapy On Cardiovascular Disease Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Gene Therapy On Cardiovascular Disease Average Price by Manufacturers (2020-2025)
3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
3.8 Gene Therapy On Cardiovascular Disease Market Competitive Situation and Trends
3.8.1 Gene Therapy On Cardiovascular Disease Market Concentration Rate
3.8.2 Global 5 and 10 Largest Gene Therapy On Cardiovascular Disease Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 GENE THERAPY ON CARDIOVASCULAR DISEASE INDUSTRY CHAIN ANALYSIS
4.1 Gene Therapy On Cardiovascular Disease Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF GENE THERAPY ON CARDIOVASCULAR DISEASE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Gene Therapy On Cardiovascular Disease Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy – April 2025
5.6.3 Global Trade Frictions and Their Impacts to Gene Therapy On Cardiovascular Disease Market
5.7 ESG Ratings of Leading Companies
6 GENE THERAPY ON CARDIOVASCULAR DISEASE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Gene Therapy On Cardiovascular Disease Sales Market Share by Type (2020-2025)
6.3 Global Gene Therapy On Cardiovascular Disease Market Size by Type (2020-2025)
6.4 Global Gene Therapy On Cardiovascular Disease Price by Type (2020-2025)
7 GENE THERAPY ON CARDIOVASCULAR DISEASE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Gene Therapy On Cardiovascular Disease Market Sales by Application (2020-2025)
7.3 Global Gene Therapy On Cardiovascular Disease Market Size (M USD) by Application (2020-2025)
7.4 Global Gene Therapy On Cardiovascular Disease Sales Growth Rate by Application (2020-2025)
8 GENE THERAPY ON CARDIOVASCULAR DISEASE MARKET SALES BY REGION
8.1 Global Gene Therapy On Cardiovascular Disease Sales by Region
8.1.1 Global Gene Therapy On Cardiovascular Disease Sales by Region
8.1.2 Global Gene Therapy On Cardiovascular Disease Sales Market Share by Region
8.2 Global Gene Therapy On Cardiovascular Disease Market Size by Region
8.2.1 Global Gene Therapy On Cardiovascular Disease Market Size by Region
8.2.2 Global Gene Therapy On Cardiovascular Disease Market Size by Region
8.3 North America
8.3.1 North America Gene Therapy On Cardiovascular Disease Sales by Country
8.3.2 North America Gene Therapy On Cardiovascular Disease Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Gene Therapy On Cardiovascular Disease Sales by Country
8.4.2 Europe Gene Therapy On Cardiovascular Disease Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Gene Therapy On Cardiovascular Disease Sales by Region
8.5.2 Asia Pacific Gene Therapy On Cardiovascular Disease Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Gene Therapy On Cardiovascular Disease Sales by Country
8.6.2 South America Gene Therapy On Cardiovascular Disease Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Gene Therapy On Cardiovascular Disease Sales by Region
8.7.2 Middle East and Africa Gene Therapy On Cardiovascular Disease Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 GENE THERAPY ON CARDIOVASCULAR DISEASE MARKET PRODUCTION BY REGION
9.1 Global Production of Gene Therapy On Cardiovascular Disease by Region(2020-2025)
9.2 Global Gene Therapy On Cardiovascular Disease Revenue Market Share by Region (2020-2025)
9.3 Global Gene Therapy On Cardiovascular Disease Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Gene Therapy On Cardiovascular Disease Production
9.4.1 North America Gene Therapy On Cardiovascular Disease Production Growth Rate (2020-2025)
9.4.2 North America Gene Therapy On Cardiovascular Disease Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Gene Therapy On Cardiovascular Disease Production
9.5.1 Europe Gene Therapy On Cardiovascular Disease Production Growth Rate (2020-2025)
9.5.2 Europe Gene Therapy On Cardiovascular Disease Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Gene Therapy On Cardiovascular Disease Production (2020-2025)
9.6.1 Japan Gene Therapy On Cardiovascular Disease Production Growth Rate (2020-2025)
9.6.2 Japan Gene Therapy On Cardiovascular Disease Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Gene Therapy On Cardiovascular Disease Production (2020-2025)
9.7.1 China Gene Therapy On Cardiovascular Disease Production Growth Rate (2020-2025)
9.7.2 China Gene Therapy On Cardiovascular Disease Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Renovacor
10.1.1 Renovacor Basic Information
10.1.2 Renovacor Gene Therapy On Cardiovascular Disease Product Overview
10.1.3 Renovacor Gene Therapy On Cardiovascular Disease Product Market Performance
10.1.4 Renovacor Business Overview
10.1.5 Renovacor SWOT Analysis
10.1.6 Renovacor Recent Developments
10.2 Gene Biotherapeutics
10.2.1 Gene Biotherapeutics Basic Information
10.2.2 Gene Biotherapeutics Gene Therapy On Cardiovascular Disease Product Overview
10.2.3 Gene Biotherapeutics Gene Therapy On Cardiovascular Disease Product Market Performance
10.2.4 Gene Biotherapeutics Business Overview
10.2.5 Gene Biotherapeutics SWOT Analysis
10.2.6 Gene Biotherapeutics Recent Developments
10.3 AskBio
10.3.1 AskBio Basic Information
10.3.2 AskBio Gene Therapy On Cardiovascular Disease Product Overview
10.3.3 AskBio Gene Therapy On Cardiovascular Disease Product Market Performance
10.3.4 AskBio Business Overview
10.3.5 AskBio SWOT Analysis
10.3.6 AskBio Recent Developments
10.4 Human Stem Cells Institute
10.4.1 Human Stem Cells Institute Basic Information
10.4.2 Human Stem Cells Institute Gene Therapy On Cardiovascular Disease Product Overview
10.4.3 Human Stem Cells Institute Gene Therapy On Cardiovascular Disease Product Market Performance
10.4.4 Human Stem Cells Institute Business Overview
10.4.5 Human Stem Cells Institute Recent Developments
10.5 Novartis
10.5.1 Novartis Basic Information
10.5.2 Novartis Gene Therapy On Cardiovascular Disease Product Overview
10.5.3 Novartis Gene Therapy On Cardiovascular Disease Product Market Performance
10.5.4 Novartis Business Overview
10.5.5 Novartis Recent Developments
10.6 Biogen
10.6.1 Biogen Basic Information
10.6.2 Biogen Gene Therapy On Cardiovascular Disease Product Overview
10.6.3 Biogen Gene Therapy On Cardiovascular Disease Product Market Performance
10.6.4 Biogen Business Overview
10.6.5 Biogen Recent Developments
10.7 Gilead Sciences
10.7.1 Gilead Sciences Basic Information
10.7.2 Gilead Sciences Gene Therapy On Cardiovascular Disease Product Overview
10.7.3 Gilead Sciences Gene Therapy On Cardiovascular Disease Product Market Performance
10.7.4 Gilead Sciences Business Overview
10.7.5 Gilead Sciences Recent Developments
10.8 SareptaTherapeutics
10.8.1 SareptaTherapeutics Basic Information
10.8.2 SareptaTherapeutics Gene Therapy On Cardiovascular Disease Product Overview
10.8.3 SareptaTherapeutics Gene Therapy On Cardiovascular Disease Product Market Performance
10.8.4 SareptaTherapeutics Business Overview
10.8.5 SareptaTherapeutics Recent Developments
10.9 Alnylam Pharmaceuticals
10.9.1 Alnylam Pharmaceuticals Basic Information
10.9.2 Alnylam Pharmaceuticals Gene Therapy On Cardiovascular Disease Product Overview
10.9.3 Alnylam Pharmaceuticals Gene Therapy On Cardiovascular Disease Product Market Performance
10.9.4 Alnylam Pharmaceuticals Business Overview
10.9.5 Alnylam Pharmaceuticals Recent Developments
10.10 Amgen
10.10.1 Amgen Basic Information
10.10.2 Amgen Gene Therapy On Cardiovascular Disease Product Overview
10.10.3 Amgen Gene Therapy On Cardiovascular Disease Product Market Performance
10.10.4 Amgen Business Overview
10.10.5 Amgen Recent Developments
10.11 Spark Therapeutics
10.11.1 Spark Therapeutics Basic Information
10.11.2 Spark Therapeutics Gene Therapy On Cardiovascular Disease Product Overview
10.11.3 Spark Therapeutics Gene Therapy On Cardiovascular Disease Product Market Performance
10.11.4 Spark Therapeutics Business Overview
10.11.5 Spark Therapeutics Recent Developments
10.12 Akcea Therapeutics
10.12.1 Akcea Therapeutics Basic Information
10.12.2 Akcea Therapeutics Gene Therapy On Cardiovascular Disease Product Overview
10.12.3 Akcea Therapeutics Gene Therapy On Cardiovascular Disease Product Market Performance
10.12.4 Akcea Therapeutics Business Overview
10.12.5 Akcea Therapeutics Recent Developments
10.13 Sunway Biotech
10.13.1 Sunway Biotech Basic Information
10.13.2 Sunway Biotech Gene Therapy On Cardiovascular Disease Product Overview
10.13.3 Sunway Biotech Gene Therapy On Cardiovascular Disease Product Market Performance
10.13.4 Sunway Biotech Business Overview
10.13.5 Sunway Biotech Recent Developments
10.14 SIBIONO
10.14.1 SIBIONO Basic Information
10.14.2 SIBIONO Gene Therapy On Cardiovascular Disease Product Overview
10.14.3 SIBIONO Gene Therapy On Cardiovascular Disease Product Market Performance
10.14.4 SIBIONO Business Overview
10.14.5 SIBIONO Recent Developments
10.15 AnGes
10.15.1 AnGes Basic Information
10.15.2 AnGes Gene Therapy On Cardiovascular Disease Product Overview
10.15.3 AnGes Gene Therapy On Cardiovascular Disease Product Market Performance
10.15.4 AnGes Business Overview
10.15.5 AnGes Recent Developments
10.16 Orchard Therapeutics
10.16.1 Orchard Therapeutics Basic Information
10.16.2 Orchard Therapeutics Gene Therapy On Cardiovascular Disease Product Overview
10.16.3 Orchard Therapeutics Gene Therapy On Cardiovascular Disease Product Market Performance
10.16.4 Orchard Therapeutics Business Overview
10.16.5 Orchard Therapeutics Recent Developments
11 GENE THERAPY ON CARDIOVASCULAR DISEASE MARKET FORECAST BY REGION
11.1 Global Gene Therapy On Cardiovascular Disease Market Size Forecast
11.2 Global Gene Therapy On Cardiovascular Disease Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Gene Therapy On Cardiovascular Disease Market Size Forecast by Country
11.2.3 Asia Pacific Gene Therapy On Cardiovascular Disease Market Size Forecast by Region
11.2.4 South America Gene Therapy On Cardiovascular Disease Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Gene Therapy On Cardiovascular Disease by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Gene Therapy On Cardiovascular Disease Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Gene Therapy On Cardiovascular Disease by Type (2026-2035)
12.1.2 Global Gene Therapy On Cardiovascular Disease Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Gene Therapy On Cardiovascular Disease by Type (2026-2035)
12.2 Global Gene Therapy On Cardiovascular Disease Market Forecast by Application (2026-2035)
12.2.1 Global Gene Therapy On Cardiovascular Disease Sales (K Units) Forecast by Application
12.2.2 Global Gene Therapy On Cardiovascular Disease Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Gene Therapy On Cardiovascular Disease Market Size by Type (M USD)
Table 4. Global Gene Therapy On Cardiovascular Disease Market Size by Application
Table 5. Gene Therapy On Cardiovascular Disease Market Size Comparison by Region (M USD)
Table 6. Global Gene Therapy On Cardiovascular Disease Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global Gene Therapy On Cardiovascular Disease Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Gene Therapy On Cardiovascular Disease Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Gene Therapy On Cardiovascular Disease Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapy On Cardiovascular Disease as of 2025)
Table 11. Global Market Gene Therapy On Cardiovascular Disease Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers’ Manufacturing Sites, Areas Served
Table 13. Manufacturers’ Product Type
Table 14. Global Gene Therapy On Cardiovascular Disease Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Gene Therapy On Cardiovascular Disease Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Gene Therapy On Cardiovascular Disease Sales by Type (K Units)
Table 27. Global Gene Therapy On Cardiovascular Disease Market Size by Type (M USD)
Table 28. Global Gene Therapy On Cardiovascular Disease Sales (K Units) by Type (2020-2025)
Table 29. Global Gene Therapy On Cardiovascular Disease Sales Market Share by Type (2020-2025)
Table 30. Global Gene Therapy On Cardiovascular Disease Market Size (M USD) by Type (2020-2025)
Table 31. Global Gene Therapy On Cardiovascular Disease Market Share by Type (2020-2025)
Table 32. Global Gene Therapy On Cardiovascular Disease Price (USD/Unit) by Type (2020-2025)
Table 33. Global Gene Therapy On Cardiovascular Disease Sales (K Units) by Application
Table 34. Global Gene Therapy On Cardiovascular Disease Market Size by Application
Table 35. Global Gene Therapy On Cardiovascular Disease Sales by Application (2020-2025) & (K Units)
Table 36. Global Gene Therapy On Cardiovascular Disease Sales Market Share by Application (2020-2025)
Table 37. Global Gene Therapy On Cardiovascular Disease Market Size by Application (2020-2025) & (M USD)
Table 38. Global Gene Therapy On Cardiovascular Disease Market Share by Application (2020-2025)
Table 39. Global Gene Therapy On Cardiovascular Disease Sales Growth Rate by Application (2020-2025)
Table 40. Global Gene Therapy On Cardiovascular Disease Sales by Region (2020-2025) & (K Units)
Table 41. Global Gene Therapy On Cardiovascular Disease Sales Market Share by Region (2020-2025)
Table 42. Global Gene Therapy On Cardiovascular Disease Market Size by Region (2020-2025) & (M USD)
Table 43. Global Gene Therapy On Cardiovascular Disease Market Size by Region (2020-2025)
Table 44. North America Gene Therapy On Cardiovascular Disease Sales by Country (2020-2025) & (K Units)
Table 45. North America Gene Therapy On Cardiovascular Disease Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Gene Therapy On Cardiovascular Disease Sales by Country (2020-2025) & (K Units)
Table 47. Europe Gene Therapy On Cardiovascular Disease Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Gene Therapy On Cardiovascular Disease Sales by Region (2020-2025) & (K Units)
Table 49. Asia Pacific Gene Therapy On Cardiovascular Disease Market Size by Region (2020-2025) & (M USD)
Table 50. South America Gene Therapy On Cardiovascular Disease Sales by Country (2020-2025) & (K Units)
Table 51. South America Gene Therapy On Cardiovascular Disease Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Gene Therapy On Cardiovascular Disease Sales by Region (2020-2025) & (K Units)
Table 53. Middle East and Africa Gene Therapy On Cardiovascular Disease Market Size by Region (2020-2025) & (M USD)
Table 54. Global Gene Therapy On Cardiovascular Disease Production (K Units) by Region(2020-2025)
Table 55. Global Gene Therapy On Cardiovascular Disease Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Gene Therapy On Cardiovascular Disease Revenue Market Share by Region (2020-2025)
Table 57. Global Gene Therapy On Cardiovascular Disease Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. North America Gene Therapy On Cardiovascular Disease Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Europe Gene Therapy On Cardiovascular Disease Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Japan Gene Therapy On Cardiovascular Disease Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. China Gene Therapy On Cardiovascular Disease Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. Renovacor Basic Information
Table 63. Renovacor Gene Therapy On Cardiovascular Disease Product Overview
Table 64. Renovacor Gene Therapy On Cardiovascular Disease Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. Renovacor Business Overview
Table 66. Renovacor SWOT Analysis
Table 67. Renovacor Recent Developments
Table 68. Gene Biotherapeutics Basic Information
Table 69. Gene Biotherapeutics Gene Therapy On Cardiovascular Disease Product Overview
Table 70. Gene Biotherapeutics Gene Therapy On Cardiovascular Disease Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 71. Gene Biotherapeutics Business Overview
Table 72. Gene Biotherapeutics SWOT Analysis
Table 73. Gene Biotherapeutics Recent Developments
Table 74. AskBio Basic Information
Table 75. AskBio Gene Therapy On Cardiovascular Disease Product Overview
Table 76. AskBio Gene Therapy On Cardiovascular Disease Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. AskBio Business Overview
Table 78. AskBio SWOT Analysis
Table 79. AskBio Recent Developments
Table 80. Human Stem Cells Institute Basic Information
Table 81. Human Stem Cells Institute Gene Therapy On Cardiovascular Disease Product Overview
Table 82. Human Stem Cells Institute Gene Therapy On Cardiovascular Disease Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Human Stem Cells Institute Business Overview
Table 84. Human Stem Cells Institute Recent Developments
Table 85. Novartis Basic Information
Table 86. Novartis Gene Therapy On Cardiovascular Disease Product Overview
Table 87. Novartis Gene Therapy On Cardiovascular Disease Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Novartis Business Overview
Table 89. Novartis Recent Developments
Table 90. Biogen Basic Information
Table 91. Biogen Gene Therapy On Cardiovascular Disease Product Overview
Table 92. Biogen Gene Therapy On Cardiovascular Disease Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Biogen Business Overview
Table 94. Biogen Recent Developments
Table 95. Gilead Sciences Basic Information
Table 96. Gilead Sciences Gene Therapy On Cardiovascular Disease Product Overview
Table 97. Gilead Sciences Gene Therapy On Cardiovascular Disease Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Gilead Sciences Business Overview
Table 99. Gilead Sciences Recent Developments
Table 100. SareptaTherapeutics Basic Information
Table 101. SareptaTherapeutics Gene Therapy On Cardiovascular Disease Product Overview
Table 102. SareptaTherapeutics Gene Therapy On Cardiovascular Disease Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. SareptaTherapeutics Business Overview
Table 104. SareptaTherapeutics Recent Developments
Table 105. Alnylam Pharmaceuticals Basic Information
Table 106. Alnylam Pharmaceuticals Gene Therapy On Cardiovascular Disease Product Overview
Table 107. Alnylam Pharmaceuticals Gene Therapy On Cardiovascular Disease Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Alnylam Pharmaceuticals Business Overview
Table 109. Alnylam Pharmaceuticals Recent Developments
Table 110. Amgen Basic Information
Table 111. Amgen Gene Therapy On Cardiovascular Disease Product Overview
Table 112. Amgen Gene Therapy On Cardiovascular Disease Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. Amgen Business Overview
Table 114. Amgen Recent Developments
Table 115. Spark Therapeutics Basic Information
Table 116. Spark Therapeutics Gene Therapy On Cardiovascular Disease Product Overview
Table 117. Spark Therapeutics Gene Therapy On Cardiovascular Disease Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. Spark Therapeutics Business Overview
Table 119. Spark Therapeutics Recent Developments
Table 120. Akcea Therapeutics Basic Information
Table 121. Akcea Therapeutics Gene Therapy On Cardiovascular Disease Product Overview
Table 122. Akcea Therapeutics Gene Therapy On Cardiovascular Disease Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 123. Akcea Therapeutics Business Overview
Table 124. Akcea Therapeutics Recent Developments
Table 125. Sunway Biotech Basic Information
Table 126. Sunway Biotech Gene Therapy On Cardiovascular Disease Product Overview
Table 127. Sunway Biotech Gene Therapy On Cardiovascular Disease Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 128. Sunway Biotech Business Overview
Table 129. Sunway Biotech Recent Developments
Table 130. SIBIONO Basic Information
Table 131. SIBIONO Gene Therapy On Cardiovascular Disease Product Overview
Table 132. SIBIONO Gene Therapy On Cardiovascular Disease Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 133. SIBIONO Business Overview
Table 134. SIBIONO Recent Developments
Table 135. AnGes Basic Information
Table 136. AnGes Gene Therapy On Cardiovascular Disease Product Overview
Table 137. AnGes Gene Therapy On Cardiovascular Disease Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 138. AnGes Business Overview
Table 139. AnGes Recent Developments
Table 140. Orchard Therapeutics Basic Information
Table 141. Orchard Therapeutics Gene Therapy On Cardiovascular Disease Product Overview
Table 142. Orchard Therapeutics Gene Therapy On Cardiovascular Disease Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 143. Orchard Therapeutics Business Overview
Table 144. Orchard Therapeutics Recent Developments
Table 145. Global Gene Therapy On Cardiovascular Disease Sales Forecast by Region (2026-2035) & (K Units)
Table 146. Global Gene Therapy On Cardiovascular Disease Market Size Forecast by Region (2026-2035) & (M USD)
Table 147. North America Gene Therapy On Cardiovascular Disease Sales Forecast by Country (2026-2035) & (K Units)
Table 148. North America Gene Therapy On Cardiovascular Disease Market Size Forecast by Country (2026-2035) & (M USD)
Table 149. Europe Gene Therapy On Cardiovascular Disease Sales Forecast by Country (2026-2035) & (K Units)
Table 150. Europe Gene Therapy On Cardiovascular Disease Market Size Forecast by Country (2026-2035) & (M USD)
Table 151. Asia Pacific Gene Therapy On Cardiovascular Disease Sales Forecast by Region (2026-2035) & (K Units)
Table 152. Asia Pacific Gene Therapy On Cardiovascular Disease Market Size Forecast by Region (2026-2035) & (M USD)
Table 153. South America Gene Therapy On Cardiovascular Disease Sales Forecast by Country (2026-2035) & (K Units)
Table 154. South America Gene Therapy On Cardiovascular Disease Market Size Forecast by Country (2026-2035) & (M USD)
Table 155. Middle East and Africa Gene Therapy On Cardiovascular Disease Sales Forecast by Country (2026-2035) & (Units)
Table 156. Middle East and Africa Gene Therapy On Cardiovascular Disease Market Size Forecast by Country (2026-2035) & (M USD)
Table 157. Global Gene Therapy On Cardiovascular Disease Sales Forecast by Type (2026-2035) & (K Units)
Table 158. Global Gene Therapy On Cardiovascular Disease Market Size Forecast by Type (2026-2035) & (M USD)
Table 159. Global Gene Therapy On Cardiovascular Disease Price Forecast by Type (2026-2035) & (USD/Unit)
Table 160. Global Gene Therapy On Cardiovascular Disease Sales (K Units) Forecast by Application (2026-2035)
Table 161. Global Gene Therapy On Cardiovascular Disease Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Gene Therapy On Cardiovascular Disease Market Size by Type (M USD)
Table 4. Global Gene Therapy On Cardiovascular Disease Market Size by Application
Table 5. Gene Therapy On Cardiovascular Disease Market Size Comparison by Region (M USD)
Table 6. Global Gene Therapy On Cardiovascular Disease Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global Gene Therapy On Cardiovascular Disease Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Gene Therapy On Cardiovascular Disease Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Gene Therapy On Cardiovascular Disease Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapy On Cardiovascular Disease as of 2025)
Table 11. Global Market Gene Therapy On Cardiovascular Disease Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers’ Manufacturing Sites, Areas Served
Table 13. Manufacturers’ Product Type
Table 14. Global Gene Therapy On Cardiovascular Disease Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Gene Therapy On Cardiovascular Disease Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Gene Therapy On Cardiovascular Disease Sales by Type (K Units)
Table 27. Global Gene Therapy On Cardiovascular Disease Market Size by Type (M USD)
Table 28. Global Gene Therapy On Cardiovascular Disease Sales (K Units) by Type (2020-2025)
Table 29. Global Gene Therapy On Cardiovascular Disease Sales Market Share by Type (2020-2025)
Table 30. Global Gene Therapy On Cardiovascular Disease Market Size (M USD) by Type (2020-2025)
Table 31. Global Gene Therapy On Cardiovascular Disease Market Share by Type (2020-2025)
Table 32. Global Gene Therapy On Cardiovascular Disease Price (USD/Unit) by Type (2020-2025)
Table 33. Global Gene Therapy On Cardiovascular Disease Sales (K Units) by Application
Table 34. Global Gene Therapy On Cardiovascular Disease Market Size by Application
Table 35. Global Gene Therapy On Cardiovascular Disease Sales by Application (2020-2025) & (K Units)
Table 36. Global Gene Therapy On Cardiovascular Disease Sales Market Share by Application (2020-2025)
Table 37. Global Gene Therapy On Cardiovascular Disease Market Size by Application (2020-2025) & (M USD)
Table 38. Global Gene Therapy On Cardiovascular Disease Market Share by Application (2020-2025)
Table 39. Global Gene Therapy On Cardiovascular Disease Sales Growth Rate by Application (2020-2025)
Table 40. Global Gene Therapy On Cardiovascular Disease Sales by Region (2020-2025) & (K Units)
Table 41. Global Gene Therapy On Cardiovascular Disease Sales Market Share by Region (2020-2025)
Table 42. Global Gene Therapy On Cardiovascular Disease Market Size by Region (2020-2025) & (M USD)
Table 43. Global Gene Therapy On Cardiovascular Disease Market Size by Region (2020-2025)
Table 44. North America Gene Therapy On Cardiovascular Disease Sales by Country (2020-2025) & (K Units)
Table 45. North America Gene Therapy On Cardiovascular Disease Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Gene Therapy On Cardiovascular Disease Sales by Country (2020-2025) & (K Units)
Table 47. Europe Gene Therapy On Cardiovascular Disease Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Gene Therapy On Cardiovascular Disease Sales by Region (2020-2025) & (K Units)
Table 49. Asia Pacific Gene Therapy On Cardiovascular Disease Market Size by Region (2020-2025) & (M USD)
Table 50. South America Gene Therapy On Cardiovascular Disease Sales by Country (2020-2025) & (K Units)
Table 51. South America Gene Therapy On Cardiovascular Disease Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Gene Therapy On Cardiovascular Disease Sales by Region (2020-2025) & (K Units)
Table 53. Middle East and Africa Gene Therapy On Cardiovascular Disease Market Size by Region (2020-2025) & (M USD)
Table 54. Global Gene Therapy On Cardiovascular Disease Production (K Units) by Region(2020-2025)
Table 55. Global Gene Therapy On Cardiovascular Disease Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Gene Therapy On Cardiovascular Disease Revenue Market Share by Region (2020-2025)
Table 57. Global Gene Therapy On Cardiovascular Disease Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. North America Gene Therapy On Cardiovascular Disease Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Europe Gene Therapy On Cardiovascular Disease Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Japan Gene Therapy On Cardiovascular Disease Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. China Gene Therapy On Cardiovascular Disease Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. Renovacor Basic Information
Table 63. Renovacor Gene Therapy On Cardiovascular Disease Product Overview
Table 64. Renovacor Gene Therapy On Cardiovascular Disease Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. Renovacor Business Overview
Table 66. Renovacor SWOT Analysis
Table 67. Renovacor Recent Developments
Table 68. Gene Biotherapeutics Basic Information
Table 69. Gene Biotherapeutics Gene Therapy On Cardiovascular Disease Product Overview
Table 70. Gene Biotherapeutics Gene Therapy On Cardiovascular Disease Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 71. Gene Biotherapeutics Business Overview
Table 72. Gene Biotherapeutics SWOT Analysis
Table 73. Gene Biotherapeutics Recent Developments
Table 74. AskBio Basic Information
Table 75. AskBio Gene Therapy On Cardiovascular Disease Product Overview
Table 76. AskBio Gene Therapy On Cardiovascular Disease Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. AskBio Business Overview
Table 78. AskBio SWOT Analysis
Table 79. AskBio Recent Developments
Table 80. Human Stem Cells Institute Basic Information
Table 81. Human Stem Cells Institute Gene Therapy On Cardiovascular Disease Product Overview
Table 82. Human Stem Cells Institute Gene Therapy On Cardiovascular Disease Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Human Stem Cells Institute Business Overview
Table 84. Human Stem Cells Institute Recent Developments
Table 85. Novartis Basic Information
Table 86. Novartis Gene Therapy On Cardiovascular Disease Product Overview
Table 87. Novartis Gene Therapy On Cardiovascular Disease Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Novartis Business Overview
Table 89. Novartis Recent Developments
Table 90. Biogen Basic Information
Table 91. Biogen Gene Therapy On Cardiovascular Disease Product Overview
Table 92. Biogen Gene Therapy On Cardiovascular Disease Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Biogen Business Overview
Table 94. Biogen Recent Developments
Table 95. Gilead Sciences Basic Information
Table 96. Gilead Sciences Gene Therapy On Cardiovascular Disease Product Overview
Table 97. Gilead Sciences Gene Therapy On Cardiovascular Disease Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Gilead Sciences Business Overview
Table 99. Gilead Sciences Recent Developments
Table 100. SareptaTherapeutics Basic Information
Table 101. SareptaTherapeutics Gene Therapy On Cardiovascular Disease Product Overview
Table 102. SareptaTherapeutics Gene Therapy On Cardiovascular Disease Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. SareptaTherapeutics Business Overview
Table 104. SareptaTherapeutics Recent Developments
Table 105. Alnylam Pharmaceuticals Basic Information
Table 106. Alnylam Pharmaceuticals Gene Therapy On Cardiovascular Disease Product Overview
Table 107. Alnylam Pharmaceuticals Gene Therapy On Cardiovascular Disease Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Alnylam Pharmaceuticals Business Overview
Table 109. Alnylam Pharmaceuticals Recent Developments
Table 110. Amgen Basic Information
Table 111. Amgen Gene Therapy On Cardiovascular Disease Product Overview
Table 112. Amgen Gene Therapy On Cardiovascular Disease Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. Amgen Business Overview
Table 114. Amgen Recent Developments
Table 115. Spark Therapeutics Basic Information
Table 116. Spark Therapeutics Gene Therapy On Cardiovascular Disease Product Overview
Table 117. Spark Therapeutics Gene Therapy On Cardiovascular Disease Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. Spark Therapeutics Business Overview
Table 119. Spark Therapeutics Recent Developments
Table 120. Akcea Therapeutics Basic Information
Table 121. Akcea Therapeutics Gene Therapy On Cardiovascular Disease Product Overview
Table 122. Akcea Therapeutics Gene Therapy On Cardiovascular Disease Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 123. Akcea Therapeutics Business Overview
Table 124. Akcea Therapeutics Recent Developments
Table 125. Sunway Biotech Basic Information
Table 126. Sunway Biotech Gene Therapy On Cardiovascular Disease Product Overview
Table 127. Sunway Biotech Gene Therapy On Cardiovascular Disease Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 128. Sunway Biotech Business Overview
Table 129. Sunway Biotech Recent Developments
Table 130. SIBIONO Basic Information
Table 131. SIBIONO Gene Therapy On Cardiovascular Disease Product Overview
Table 132. SIBIONO Gene Therapy On Cardiovascular Disease Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 133. SIBIONO Business Overview
Table 134. SIBIONO Recent Developments
Table 135. AnGes Basic Information
Table 136. AnGes Gene Therapy On Cardiovascular Disease Product Overview
Table 137. AnGes Gene Therapy On Cardiovascular Disease Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 138. AnGes Business Overview
Table 139. AnGes Recent Developments
Table 140. Orchard Therapeutics Basic Information
Table 141. Orchard Therapeutics Gene Therapy On Cardiovascular Disease Product Overview
Table 142. Orchard Therapeutics Gene Therapy On Cardiovascular Disease Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 143. Orchard Therapeutics Business Overview
Table 144. Orchard Therapeutics Recent Developments
Table 145. Global Gene Therapy On Cardiovascular Disease Sales Forecast by Region (2026-2035) & (K Units)
Table 146. Global Gene Therapy On Cardiovascular Disease Market Size Forecast by Region (2026-2035) & (M USD)
Table 147. North America Gene Therapy On Cardiovascular Disease Sales Forecast by Country (2026-2035) & (K Units)
Table 148. North America Gene Therapy On Cardiovascular Disease Market Size Forecast by Country (2026-2035) & (M USD)
Table 149. Europe Gene Therapy On Cardiovascular Disease Sales Forecast by Country (2026-2035) & (K Units)
Table 150. Europe Gene Therapy On Cardiovascular Disease Market Size Forecast by Country (2026-2035) & (M USD)
Table 151. Asia Pacific Gene Therapy On Cardiovascular Disease Sales Forecast by Region (2026-2035) & (K Units)
Table 152. Asia Pacific Gene Therapy On Cardiovascular Disease Market Size Forecast by Region (2026-2035) & (M USD)
Table 153. South America Gene Therapy On Cardiovascular Disease Sales Forecast by Country (2026-2035) & (K Units)
Table 154. South America Gene Therapy On Cardiovascular Disease Market Size Forecast by Country (2026-2035) & (M USD)
Table 155. Middle East and Africa Gene Therapy On Cardiovascular Disease Sales Forecast by Country (2026-2035) & (Units)
Table 156. Middle East and Africa Gene Therapy On Cardiovascular Disease Market Size Forecast by Country (2026-2035) & (M USD)
Table 157. Global Gene Therapy On Cardiovascular Disease Sales Forecast by Type (2026-2035) & (K Units)
Table 158. Global Gene Therapy On Cardiovascular Disease Market Size Forecast by Type (2026-2035) & (M USD)
Table 159. Global Gene Therapy On Cardiovascular Disease Price Forecast by Type (2026-2035) & (USD/Unit)
Table 160. Global Gene Therapy On Cardiovascular Disease Sales (K Units) Forecast by Application (2026-2035)
Table 161. Global Gene Therapy On Cardiovascular Disease Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Gene Therapy On Cardiovascular Disease
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Gene Therapy On Cardiovascular Disease Market Size (M USD), 2025-2035
Figure 5. Global Gene Therapy On Cardiovascular Disease Market Size (M USD) (2020-2035)
Figure 6. Global Gene Therapy On Cardiovascular Disease Sales (K Units) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Gene Therapy On Cardiovascular Disease Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Gene Therapy On Cardiovascular Disease Product Life Cycle
Figure 13. Gene Therapy On Cardiovascular Disease Sales Share by Manufacturers in 2025
Figure 14. Global Gene Therapy On Cardiovascular Disease Revenue Share by Manufacturers in 2025
Figure 15. Gene Therapy On Cardiovascular Disease Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Gene Therapy On Cardiovascular Disease Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Gene Therapy On Cardiovascular Disease Revenue in 2025
Figure 18. Industry Chain Map of Gene Therapy On Cardiovascular Disease
Figure 19. Global Gene Therapy On Cardiovascular Disease Market PEST Analysis
Figure 20. Global Gene Therapy On Cardiovascular Disease Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Gene Therapy On Cardiovascular Disease Market Share by Type
Figure 27. Sales Market Share of Gene Therapy On Cardiovascular Disease by Type (2020-2025)
Figure 28. Sales Market Share of Gene Therapy On Cardiovascular Disease by Type in 2025
Figure 29. Market Share of Gene Therapy On Cardiovascular Disease by Type (2020-2025)
Figure 30. Market Share of Gene Therapy On Cardiovascular Disease by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Gene Therapy On Cardiovascular Disease Market Share by Application
Figure 33. Global Gene Therapy On Cardiovascular Disease Sales Market Share by Application (2020-2025)
Figure 34. Global Gene Therapy On Cardiovascular Disease Sales Market Share by Application in 2025
Figure 35. Global Gene Therapy On Cardiovascular Disease Market Share by Application (2020-2025)
Figure 36. Global Gene Therapy On Cardiovascular Disease Market Share by Application in 2025
Figure 37. Global Gene Therapy On Cardiovascular Disease Sales Growth Rate by Application (2020-2025)
Figure 38. Global Gene Therapy On Cardiovascular Disease Sales Market Share by Region (2020-2025)
Figure 39. Global Gene Therapy On Cardiovascular Disease Market Size by Region (2020-2025)
Figure 40. North America Gene Therapy On Cardiovascular Disease Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Gene Therapy On Cardiovascular Disease Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Gene Therapy On Cardiovascular Disease Sales Market Share by Country in 2024
Figure 43. North America Gene Therapy On Cardiovascular Disease Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Gene Therapy On Cardiovascular Disease Market Size by Country in 2024
Figure 45. U.S. Gene Therapy On Cardiovascular Disease Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Gene Therapy On Cardiovascular Disease Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Gene Therapy On Cardiovascular Disease Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Gene Therapy On Cardiovascular Disease Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Gene Therapy On Cardiovascular Disease Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Gene Therapy On Cardiovascular Disease Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Gene Therapy On Cardiovascular Disease Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Gene Therapy On Cardiovascular Disease Sales Market Share by Country in 2024
Figure 53. Europe Gene Therapy On Cardiovascular Disease Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Gene Therapy On Cardiovascular Disease Market Size by Country in 2024
Figure 55. Germany Gene Therapy On Cardiovascular Disease Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Gene Therapy On Cardiovascular Disease Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Gene Therapy On Cardiovascular Disease Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Gene Therapy On Cardiovascular Disease Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Gene Therapy On Cardiovascular Disease Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Gene Therapy On Cardiovascular Disease Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Gene Therapy On Cardiovascular Disease Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Gene Therapy On Cardiovascular Disease Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Gene Therapy On Cardiovascular Disease Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Gene Therapy On Cardiovascular Disease Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Gene Therapy On Cardiovascular Disease Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Gene Therapy On Cardiovascular Disease Sales Market Share by Region in 2024
Figure 67. Asia Pacific Gene Therapy On Cardiovascular Disease Market Size by Region in 2024
Figure 68. China Gene Therapy On Cardiovascular Disease Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Gene Therapy On Cardiovascular Disease Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Gene Therapy On Cardiovascular Disease Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Gene Therapy On Cardiovascular Disease Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Gene Therapy On Cardiovascular Disease Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Gene Therapy On Cardiovascular Disease Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Gene Therapy On Cardiovascular Disease Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Gene Therapy On Cardiovascular Disease Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Gene Therapy On Cardiovascular Disease Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Gene Therapy On Cardiovascular Disease Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Gene Therapy On Cardiovascular Disease Sales and Growth Rate (K Units)
Figure 79. South America Gene Therapy On Cardiovascular Disease Sales Market Share by Country in 2024
Figure 80. South America Gene Therapy On Cardiovascular Disease Market Size and Growth Rate (M USD)
Figure 81. South America Gene Therapy On Cardiovascular Disease Market Size by Country in 2024
Figure 82. Brazil Gene Therapy On Cardiovascular Disease Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Gene Therapy On Cardiovascular Disease Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Gene Therapy On Cardiovascular Disease Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Gene Therapy On Cardiovascular Disease Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Gene Therapy On Cardiovascular Disease Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Gene Therapy On Cardiovascular Disease Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Gene Therapy On Cardiovascular Disease Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Gene Therapy On Cardiovascular Disease Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Gene Therapy On Cardiovascular Disease Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Gene Therapy On Cardiovascular Disease Market Size by Region in 2024
Figure 92. Saudi Arabia Gene Therapy On Cardiovascular Disease Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Gene Therapy On Cardiovascular Disease Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Gene Therapy On Cardiovascular Disease Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Gene Therapy On Cardiovascular Disease Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Gene Therapy On Cardiovascular Disease Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Gene Therapy On Cardiovascular Disease Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Gene Therapy On Cardiovascular Disease Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Gene Therapy On Cardiovascular Disease Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Gene Therapy On Cardiovascular Disease Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Gene Therapy On Cardiovascular Disease Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Gene Therapy On Cardiovascular Disease Production Market Share by Region (2020-2025)
Figure 103. North America Gene Therapy On Cardiovascular Disease Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Gene Therapy On Cardiovascular Disease Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Gene Therapy On Cardiovascular Disease Production (K Units) Growth Rate (2020-2025)
Figure 106. China Gene Therapy On Cardiovascular Disease Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Gene Therapy On Cardiovascular Disease Sales Forecast by Volume (2020-2035) & (K Units)
Figure 108. Global Gene Therapy On Cardiovascular Disease Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Gene Therapy On Cardiovascular Disease Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Gene Therapy On Cardiovascular Disease Market Share Forecast by Type (2026-2035)
Figure 111. Global Gene Therapy On Cardiovascular Disease Sales Forecast by Application (2026-2035)
Figure 112. Global Gene Therapy On Cardiovascular Disease Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of Gene Therapy On Cardiovascular Disease
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Gene Therapy On Cardiovascular Disease Market Size (M USD), 2025-2035
Figure 5. Global Gene Therapy On Cardiovascular Disease Market Size (M USD) (2020-2035)
Figure 6. Global Gene Therapy On Cardiovascular Disease Sales (K Units) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Gene Therapy On Cardiovascular Disease Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Gene Therapy On Cardiovascular Disease Product Life Cycle
Figure 13. Gene Therapy On Cardiovascular Disease Sales Share by Manufacturers in 2025
Figure 14. Global Gene Therapy On Cardiovascular Disease Revenue Share by Manufacturers in 2025
Figure 15. Gene Therapy On Cardiovascular Disease Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Gene Therapy On Cardiovascular Disease Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Gene Therapy On Cardiovascular Disease Revenue in 2025
Figure 18. Industry Chain Map of Gene Therapy On Cardiovascular Disease
Figure 19. Global Gene Therapy On Cardiovascular Disease Market PEST Analysis
Figure 20. Global Gene Therapy On Cardiovascular Disease Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Gene Therapy On Cardiovascular Disease Market Share by Type
Figure 27. Sales Market Share of Gene Therapy On Cardiovascular Disease by Type (2020-2025)
Figure 28. Sales Market Share of Gene Therapy On Cardiovascular Disease by Type in 2025
Figure 29. Market Share of Gene Therapy On Cardiovascular Disease by Type (2020-2025)
Figure 30. Market Share of Gene Therapy On Cardiovascular Disease by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Gene Therapy On Cardiovascular Disease Market Share by Application
Figure 33. Global Gene Therapy On Cardiovascular Disease Sales Market Share by Application (2020-2025)
Figure 34. Global Gene Therapy On Cardiovascular Disease Sales Market Share by Application in 2025
Figure 35. Global Gene Therapy On Cardiovascular Disease Market Share by Application (2020-2025)
Figure 36. Global Gene Therapy On Cardiovascular Disease Market Share by Application in 2025
Figure 37. Global Gene Therapy On Cardiovascular Disease Sales Growth Rate by Application (2020-2025)
Figure 38. Global Gene Therapy On Cardiovascular Disease Sales Market Share by Region (2020-2025)
Figure 39. Global Gene Therapy On Cardiovascular Disease Market Size by Region (2020-2025)
Figure 40. North America Gene Therapy On Cardiovascular Disease Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Gene Therapy On Cardiovascular Disease Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Gene Therapy On Cardiovascular Disease Sales Market Share by Country in 2024
Figure 43. North America Gene Therapy On Cardiovascular Disease Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Gene Therapy On Cardiovascular Disease Market Size by Country in 2024
Figure 45. U.S. Gene Therapy On Cardiovascular Disease Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Gene Therapy On Cardiovascular Disease Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Gene Therapy On Cardiovascular Disease Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Gene Therapy On Cardiovascular Disease Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Gene Therapy On Cardiovascular Disease Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Gene Therapy On Cardiovascular Disease Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Gene Therapy On Cardiovascular Disease Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Gene Therapy On Cardiovascular Disease Sales Market Share by Country in 2024
Figure 53. Europe Gene Therapy On Cardiovascular Disease Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Gene Therapy On Cardiovascular Disease Market Size by Country in 2024
Figure 55. Germany Gene Therapy On Cardiovascular Disease Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Gene Therapy On Cardiovascular Disease Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Gene Therapy On Cardiovascular Disease Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Gene Therapy On Cardiovascular Disease Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Gene Therapy On Cardiovascular Disease Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Gene Therapy On Cardiovascular Disease Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Gene Therapy On Cardiovascular Disease Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Gene Therapy On Cardiovascular Disease Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Gene Therapy On Cardiovascular Disease Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Gene Therapy On Cardiovascular Disease Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Gene Therapy On Cardiovascular Disease Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Gene Therapy On Cardiovascular Disease Sales Market Share by Region in 2024
Figure 67. Asia Pacific Gene Therapy On Cardiovascular Disease Market Size by Region in 2024
Figure 68. China Gene Therapy On Cardiovascular Disease Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Gene Therapy On Cardiovascular Disease Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Gene Therapy On Cardiovascular Disease Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Gene Therapy On Cardiovascular Disease Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Gene Therapy On Cardiovascular Disease Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Gene Therapy On Cardiovascular Disease Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Gene Therapy On Cardiovascular Disease Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Gene Therapy On Cardiovascular Disease Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Gene Therapy On Cardiovascular Disease Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Gene Therapy On Cardiovascular Disease Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Gene Therapy On Cardiovascular Disease Sales and Growth Rate (K Units)
Figure 79. South America Gene Therapy On Cardiovascular Disease Sales Market Share by Country in 2024
Figure 80. South America Gene Therapy On Cardiovascular Disease Market Size and Growth Rate (M USD)
Figure 81. South America Gene Therapy On Cardiovascular Disease Market Size by Country in 2024
Figure 82. Brazil Gene Therapy On Cardiovascular Disease Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Gene Therapy On Cardiovascular Disease Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Gene Therapy On Cardiovascular Disease Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Gene Therapy On Cardiovascular Disease Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Gene Therapy On Cardiovascular Disease Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Gene Therapy On Cardiovascular Disease Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Gene Therapy On Cardiovascular Disease Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Gene Therapy On Cardiovascular Disease Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Gene Therapy On Cardiovascular Disease Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Gene Therapy On Cardiovascular Disease Market Size by Region in 2024
Figure 92. Saudi Arabia Gene Therapy On Cardiovascular Disease Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Gene Therapy On Cardiovascular Disease Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Gene Therapy On Cardiovascular Disease Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Gene Therapy On Cardiovascular Disease Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Gene Therapy On Cardiovascular Disease Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Gene Therapy On Cardiovascular Disease Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Gene Therapy On Cardiovascular Disease Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Gene Therapy On Cardiovascular Disease Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Gene Therapy On Cardiovascular Disease Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Gene Therapy On Cardiovascular Disease Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Gene Therapy On Cardiovascular Disease Production Market Share by Region (2020-2025)
Figure 103. North America Gene Therapy On Cardiovascular Disease Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Gene Therapy On Cardiovascular Disease Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Gene Therapy On Cardiovascular Disease Production (K Units) Growth Rate (2020-2025)
Figure 106. China Gene Therapy On Cardiovascular Disease Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Gene Therapy On Cardiovascular Disease Sales Forecast by Volume (2020-2035) & (K Units)
Figure 108. Global Gene Therapy On Cardiovascular Disease Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Gene Therapy On Cardiovascular Disease Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Gene Therapy On Cardiovascular Disease Market Share Forecast by Type (2026-2035)
Figure 111. Global Gene Therapy On Cardiovascular Disease Sales Forecast by Application (2026-2035)
Figure 112. Global Gene Therapy On Cardiovascular Disease Market Share Forecast by Application (2026-2035)
More Publications
Global Vital Signs Monitoring Devices Market Research Report 2026(Status and Outlook)
US$ 2,980.00
February 2026
153 pages
Global Cell Sorter Market Research Report 2025(Status and Outlook)
US$ 3,200.00
August 2025
136 pages
Global Orthopedic Braces Supports Market Research Report 2025(Status and Outlook)
US$ 3,200.00
July 2025
156 pages
Global Medical Guide Wire Market Research Report 2025(Status and Outlook)
US$ 3,200.00
July 2025
168 pages
Global Closed System Drug Transfer Device (CSTD) Market Research Report 2025(Status and Outlook)
US$ 3,200.00
July 2025
137 pages
